ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

DAVID HEUSINKVELD MD

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,839Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 1121

$1.37M Total Retail Price of All Prescriptions

Rank: 26 out of 1121

810 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 810 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 810 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 19,328 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LISINOPRIL 782 652 1 4
SIMVASTATIN 765 678 2 1
LEVOTHYROXINE SODIUM 747 674 3 2
HYDROCODONE-ACETAMINOPHEN 693 571 S3 4 3
OMEPRAZOLE 621 549 5 6
AMLODIPINE BESYLATE 514 475 6 5
FUROSEMIDE 471 439 7 7
WARFARIN SODIUM 465 419 8 11
GABAPENTIN 433 333 9 13
CITALOPRAM HBR 397 359 10 18
DONEPEZIL HCL 395 388 11 35
TRAZODONE HCL 322 267 12 40
CYMBALTA 288 232 13 50
METOPROLOL TARTRATE 279 225 14 9
ATORVASTATIN CALCIUM 278 249 15 15
NAMENDA 254 254 16 53
MIRTAZAPINE 253 250 17 56
FAMOTIDINE 223 202 18 63
PANTOPRAZOLE SODIUM 221 193 19 29
POTASSIUM CHLORIDE 216 199 20 12
CARVEDILOL 209 188 21 20
FLUTICASONE PROPIONATE 204 183 22 36
GLIMEPIRIDE 202 176 23 34
TRIAMTERENE-HCTZ 201 195 24 38
METFORMIN HCL 199 141 25 8
METOPROLOL SUCCINATE 181 158 26 23
ZOLPIDEM TARTRATE 178 122 27 19
LOSARTAN POTASSIUM 177 157 28 17
CLOPIDOGREL 176 161 29 27
MELOXICAM 170 143 30 22
ALENDRONATE SODIUM 168 168 31 37
PRAVASTATIN SODIUM 167 155 32 14
POLYETHYLENE GLYCOL 3350 163 149 33 70
QUETIAPINE FUMARATE 157 132 34 75
SERTRALINE HCL 156 136 35 21
LANTUS 155 100 36 52
ESCITALOPRAM OXALATE 151 143 37 94
ATENOLOL 147 127 38 16
RANITIDINE HCL 143 104 39 33
PLAVIX 143 133 39 42
NEXIUM 137 101 41 24
HYDROCHLOROTHIAZIDE 135 127 42 10
ZETIA 133 103 43 80
EXELON 131 131 44 119
CRESTOR 130 114 45 28
BYSTOLIC 129 129 46 121
LOSARTAN-HYDROCHLOROTHIAZIDE 125 124 47 46
OXYCODONE HCL-ACETAMINOPHEN 120 66 S2 48 86
ALLOPURINOL 115 111 49 30
JANUVIA 107 91 50 81
TAMSULOSIN HCL 105 66 51 32
DIVALPROEX SODIUM 102 61 52 98
DIOVAN 100 84 53 45
CIPROFLOXACIN HCL 99 89 54 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 99 99 54 31
OLANZAPINE 96 72 56 181
RISPERIDONE 93 75 57 82
METFORMIN HCL ER 92 74 58 47
LEVETIRACETAM 92 59 58 125
SEROQUEL 90 71 60 134
AZITHROMYCIN 89 80 61 44
LYRICA 85 74 62 76
ISOSORBIDE MONONITRATE ER 81 72 63 62
PREDNISONE 81 73 63 43
DIGOXIN 80 76 65 59
IPRATROPIUM-ALBUTEROL 78 64 66 160
IRBESARTAN 77 73 67 251
TRAMADOL HCL 77 53 67 25
NOVOLIN R 76 58 69 174
FENTANYL 76 69 S2 69 100
PAROXETINE HCL 76 52 69 58
ENALAPRIL MALEATE 75 75 72 73
PREMARIN 74 53 R 73 96
LOVASTATIN 74 68 73 26
AMITRIPTYLINE HCL 72 60 R 75 61
FLUOXETINE HCL 71 56 76 60
ABILIFY 71 58 76 216
PROMETHAZINE HCL 71 34 R 76 67
SINGULAIR 71 71 76 78
VERAPAMIL ER 67 46 80 89
VENLAFAXINE HCL ER 65 46 81 113
BUSPIRONE HCL 64 64 82 114
BUPROPION HCL SR 63 42 83 205
KLOR-CON M10 63 63 83 171
SPIRIVA 63 51 83 49
MORPHINE SULFATE 62 23 S2 86 238
HYDRALAZINE HCL 62 51 86 66
SYNTHROID 61 54 88 55
INSULIN SYRINGE 61 37 88 77
PROPRANOLOL HCL 59 51 90 123
LAMOTRIGINE 58 31 91 187
SPIRONOLACTONE 58 54 91 54
CARBIDOPA-LEVODOPA 58 55 91 118
NOVOLOG 58 49 91 139
NYSTOP 57 51 95 290
TRICOR 57 40 95 126
KLOR-CON M20 56 50 97 85
PROAIR HFA 56 17 97 48
LEVOFLOXACIN 54 47 99 79
FINASTERIDE 54 43 99 117
ROPINIROLE HCL 54 46 99 91
OXYCODONE-ACETAMINOPHEN 52 39 S2 102 122
AGGRENOX 52 34 102 177
DICLOFENAC SODIUM 52 23 102 112
CLONIDINE HCL 51 46 105 39
GALANTAMINE HBR 51 51 105 243
CELEBREX 51 51 105 104
AMIODARONE HCL 50 46 108 188
BUMETANIDE 50 44 108 152
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 15, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.